BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 38093305)

  • 1. ZEB1 hypermethylation is associated with better prognosis in patients with colon cancer.
    Fernandez-De-Los-Reyes I; Gomez-Dorronsoro M; Monreal-Santesteban I; Fernandez-Fernandez A; Fraga M; Azcue P; Alonso L; Fernandez-Marlasca B; Suarez J; Cordoba-Iturriagagoitia A; Guerrero-Setas D
    Clin Epigenetics; 2023 Dec; 15(1):193. PubMed ID: 38093305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding ribonucleic acid zinc finger antisense 1 promotes the progression of colonic cancer by modulating ZEB1 expression.
    Fang C; Zan J; Yue B; Liu C; He C; Yan D
    J Gastroenterol Hepatol; 2017 Jun; 32(6):1204-1211. PubMed ID: 27862275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 4. CDX2 prognostic value in stage II/III resected colon cancer is related to CMS classification.
    Pilati C; Taieb J; Balogoun R; Marisa L; de Reyniès A; Laurent-Puig P
    Ann Oncol; 2017 May; 28(5):1032-1035. PubMed ID: 28328000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced
    Kitz J; Lefebvre C; Carlos J; Lowes LE; Allan AL
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic epigenetic regulation of the microRNA-200 family mediates epithelial and mesenchymal transitions in human tumorigenesis.
    Davalos V; Moutinho C; Villanueva A; Boque R; Silva P; Carneiro F; Esteller M
    Oncogene; 2012 Apr; 31(16):2062-74. PubMed ID: 21874049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.
    Jang MH; Kim HJ; Kim EJ; Chung YR; Park SY
    Hum Pathol; 2015 Sep; 46(9):1267-74. PubMed ID: 26170011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal-epithelial transition in lymph node metastases of oral squamous cell carcinoma is accompanied by ZEB1 expression.
    Horny K; Sproll C; Peiffer L; Furtmann F; Gerhardt P; Gravemeyer J; Stoecklein NH; Spassova I; Becker JC
    J Transl Med; 2023 Apr; 21(1):267. PubMed ID: 37076857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic silencing of miR-200c in breast cancer is associated with aggressiveness and is modulated by ZEB1.
    Damiano V; Brisotto G; Borgna S; di Gennaro A; Armellin M; Perin T; Guardascione M; Maestro R; Santarosa M
    Genes Chromosomes Cancer; 2017 Feb; 56(2):147-158. PubMed ID: 27717206
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct repression of MYB by ZEB1 suppresses proliferation and epithelial gene expression during epithelial-to-mesenchymal transition of breast cancer cells.
    Hugo HJ; Pereira L; Suryadinata R; Drabsch Y; Gonda TJ; Gunasinghe NP; Pinto C; Soo ET; van Denderen BJ; Hill P; Ramsay RG; Sarcevic B; Newgreen DF; Thompson EW
    Breast Cancer Res; 2013 Nov; 15(6):R113. PubMed ID: 24283570
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PRMT1 expression in renal cell tumors- application in differential diagnosis and prognostic relevance.
    Filipović J; Bosić M; Ćirović S; Životić M; Dunđerović D; Đorđević D; Živković-Perišić S; Lipkovski A; Marković-Lipkovski J
    Diagn Pathol; 2019 Oct; 14(1):120. PubMed ID: 31655611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A modified protein marker panel to identify four consensus molecular subtypes in colorectal cancer using immunohistochemistry.
    Li X; Larsson P; Ljuslinder I; Ling A; Löfgren-Burström A; Zingmark C; Edin S; Palmqvist R
    Pathol Res Pract; 2021 Apr; 220():153379. PubMed ID: 33721619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Programmed death-ligand 1 expression at tumor invasive front is associated with epithelial-mesenchymal transition and poor prognosis in esophageal squamous cell carcinoma.
    Tsutsumi S; Saeki H; Nakashima Y; Ito S; Oki E; Morita M; Oda Y; Okano S; Maehara Y
    Cancer Sci; 2017 Jun; 108(6):1119-1127. PubMed ID: 28294486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of zinc finger E-box binding homeobox factor 1 promotes tumor invasiveness and confers unfavorable prognosis in esophageal squamous cell carcinoma.
    Yang X; Wang Q; Dai W; Zhang J; Chen X
    Tumour Biol; 2014 Dec; 35(12):11977-84. PubMed ID: 25142232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low PRRX1 expression and high ZEB1 expression are significantly correlated with epithelial-mesenchymal transition and tumor angiogenesis in non-small cell lung cancer.
    Yang R; Liu Y; Wang Y; Wang X; Ci H; Song C; Wu S
    Medicine (Baltimore); 2021 Jan; 100(4):e24472. PubMed ID: 33530259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nesfatin-1/Nucleobindin-2 enhances cell migration, invasion, and epithelial-mesenchymal transition via LKB1/AMPK/TORC1/ZEB1 pathways in colon cancer.
    Kan JY; Yen MC; Wang JY; Wu DC; Chiu YJ; Ho YW; Kuo PL
    Oncotarget; 2016 May; 7(21):31336-49. PubMed ID: 27150059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of Proliferation and Epithelial-to-Mesenchymal Transition (EMT) of Gastric Cancer by ZEB1 via Modulating Wnt5a and Related Mechanisms.
    Xue Y; Zhang L; Zhu Y; Ke X; Wang Q; Min H
    Med Sci Monit; 2019 Mar; 25():1663-1670. PubMed ID: 30829316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of E-cadherin, Beta-catenin, N-cadherin, ZEB1 and αSMA as Epithelial Mesenchymal Transition markers with prognostic factors in early and advanced stage laryngeal squamous cell carcinomas.
    Kucuk U; Ekmekci S; Talu CK; Pekcevik Y; Cukurova I
    Indian J Pathol Microbiol; 2023; 66(2):237-245. PubMed ID: 37077062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of epithelial-mesenchymal transition markers in prostate cancer.
    Figiel S; Vasseur C; Bruyere F; Rozet F; Maheo K; Fromont G
    Hum Pathol; 2017 Mar; 61():26-32. PubMed ID: 27818287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological significance of SOX4 and epithelial-mesenchymal transition markers in patients with laryngeal squamous cell carcinoma.
    Zhang M; Li H; Han Y; Wang M; Zhang J; Ma S
    Medicine (Baltimore); 2021 Mar; 100(12):e25028. PubMed ID: 33761659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.